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Abstract
The Tumor Susceptibility Gene 101 (Tsg101) encodes a multi-domain protein that mediates a variety of molecular and
biological processes including the trafficking and lysosomal degradation of cell surface receptors. Conventional and
conditional knockout models have demonstrated an essential requirement of this gene for cell cycle progression and cell
viability, but the consequences of a complete ablation of Tsg101 on intracellular processes have not been examined to date.
In this study, we employed mouse embryonic fibroblasts that carry two Tsg101 conditional knockout alleles to investigate
the expression of ErbB receptor tyrosine kinases as well as stress-induced intracellular processes that are known to be
associated with a defect in growth and cell survival. The conditional deletion of the Tsg101 gene in this well-controlled
experimental model resulted in a significant reduction in the steady-state levels of the EGFR and ErbB2 but a stress-induced
elevation in the phosphorylation of mitogen activated protein (MAP) kinases independent of growth factor stimulation. As
part of an integrated stress response, Tsg101-deficient cells exhibited extensive remodeling of actin filaments and greatly
enlarged lysosomes that were enriched with the autophagy-related protein LC3. The increase in the transcriptional
activation and expression of LC3 and its association with Lamp1-positive lysosomes in a PI3K-dependent manner suggest
that Tsg101 knockout cells utilize autophagy as a survival mechanism prior to their ultimate death. Collectively, this study
shows that a knockout of the Tsg101 gene causes complex intracellular changes associated with stress response and cell
death. These multifaceted alterations need to be recognized as they have an impact on defining particular functions for
Tsg101 in processes such as signal transduction and lysosomal/endosomal trafficking.
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Introduction
The Tumor Susceptibility Gene 101 (Tsg101) was originally
identified in transformed NIH3T3 cells using a random antisense
knockdown approach [1]. This gene encodes a multi-domain
protein that mediates a variety of molecular and biological
processes. The earliest examination of structural features and
cellular functions of Tsg101 showed that this protein may play a
role in the regulation of transcription [2,3] as well as ubiquitina-
tion [4,5]. Following the cloning and sequencing of the entire
Tsg101 gene and revising its genomic architecture and coding
sequence [6,7], we performed a computational analysis to
identify homologous proteins using the Sequence Alignment and
Modeling System (SAM T98) [8]. While this preliminary study
confirmed that the N-terminal portion of Tsg101 is similar to
ubiquitin conjugating enzymes, we also found that the predicted
Tsg101 structure exhibited an even stronger homology to
dynactin, which is involved in the movement of vesicles and
organelles along microtubules (McQueen and Wagner, unpub-
lished). Since its classification as the mammalian ortholog of the
yeast Vps23p/Stp22p by Li et al. [9] and Babst et al. [10], Tsg101
has been recognized as an integral component of the endosomal
sorting complex required for transport (ESCRT)-I, which is
involved in the ubiquitin-dependent sorting of proteins into
endosomes.
The phenotypic examination of the first conventional knockout
model by Ruland and colleagues [11] showed that Tsg101 is
essential for early embryonic development. To investigate the role
of this gene during normal organogenesis and carcinogenesis, our
laboratory generated Tsg101 conditional knockout mice that allow
a temporally and spatially controlled ablation of this gene in
postnatal animals and derived cell types. In sharp contrast to the
previously proposed tumor suppressive role of this gene, mice that
lack Tsg101 in various tissues including the mammary epithelium
did not develop preneoplastic lesions and cancer [12,13].
Moreover, the Cre/loxP-based conditional deletion of the
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30promoter and first coding exon of the Tsg101 gene resulted in a
p53-mediated cell cycle arrest. Subsequently, Tsg101-deficient
cells undergo apoptosis that is independent of functional p53,
p19
Arf, or p21
Cip/Waf [12,14]. The ubiquitously expressed Tsg101
gene possesses all the hallmarks of a housekeeping gene [6], and
the collective studies on Tsg101 knockout cells confirmed that the
essential functions of this gene for cell proliferation and survival
seem to apply to all cell types that have been examined thus far
including those that have undergone neoplastic transformation
[14–16]. In support of this notion, recent work from various
research teams including our own shows that Tsg101 is
overexpressed rather than lost in a subset of breast, lung, thyroid,
ovarian, and colon cancers [17–21].
As a member of the heterotetrameric ESCRT-I complex,
Tsg101 associates with other vacuolar sorting proteins [Vps28,
Vps37, and the multivesicular body protein 12 (MVB-12)] and
facilitates the binding and sorting of ubiquitinated cargo proteins
through its ubiquitin-conjugating enzyme E2 variant (UEV)
domain. Here, Tsg101 is suggested to mediate multifaceted
intracellular functions such as the downregulation of ubi-
quitinated cell surface receptors, in particular EGFR [10,22–24],
autophagic clearance of certain proteins aggregates [25],
cytokinesis [26], and viral egress from infected cells [27,28].
Despite a wealth of information about these proposed intracellular
functions of the Tsg101 protein, it is still a conundrum why
a knockout of the mammalian Tsg101 gene causes cell cycle
arrest and cell death instead of accelerated growth and tumor
formation.
The aim of this study was to examine the effect of a conditional
deletion of the Tsg101 gene on stress-induced intracellular
processes that might be associated with a defect in growth and
cell survival as well as the expression of ErbB receptor tyrosine
kinases, which have never been examined in Tsg101 knockout
cells. Collectively, the finding show that the deletion of Tsg101
resulted in a significant reduction in the steady-state levels of the
EGFR and ErbB2. In addition, Tsg101 knockout cells developed
enlarged lysosomes that were enriched with the autophagy-related
protein LC3. A significant increase in the expression of LC3 and
its association with Lamp1-positive lysosomes in a PI3K-
dependent manner suggest that cells lacking Tsg101 seem to
utilize autophagy as a survival mechanism prior to their ultimate
death.
Figure 1. A conditional knockout of Tsg101 results in reduced expression of EGFR and ErbB2 but a stress-induced activation of
Erk1/2 in a growth factor independent manner. A., B. Western blot analyses to assess the steady-state levels of endogenous EGFR and ErbB2
(A) as well as exogenous human EGFR in Tsg101 (B) conditional knockout fibroblasts (2/2) and their isogenic controls expressing Tsg101 (fl/fl). C.
Semi-quantitative RT-PCR to examine the transcriptional activation of the endogenous EGFR gene in response to Tsg101 ablation. Genomic DNA
(gDNA) was used as a control for the PCR with exon-specific primers that span intronic sequences of the mouse EGFR. D. EGFR and Erk1/2 expression
and activation in response to EGF stimulation (0, 30, and 60 min) in cells lacking Tsg101 and their isogenic controls. E. Western blot analysis to assess
immediate and long-term changes in EGFR expression and activation of Erk1/2 between one and four days following the conditional deletion of
Tsg101. F. Analysis of Erk1/2 phosphorylation in the presence and absence of growth factors (GF) in response to Tsg101 deficiency.
doi:10.1371/journal.pone.0034308.g001
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Tsg101 deficiency leads to a decline in EGFR expression
and signaling but induces a growth-factor independent
phosphorylation of Erk1/2
We previously generated immortal mouse embryonic fibroblast
(MEFs) cell lines that carry two conditional knockout alleles of the
Tsg101 gene (Tsg101
fl/fl) that can be excised from the genome
upon expression of Cre recombinase [12,14]. Infection of these
cells with a pBabe-Cre retroviral vector and selection with
puromycin led to a substantial downregulation of the Tsg101
protein (Fig. 1). Since Tsg101 has been suggested to regulate
the expression and trafficking of active ErbB receptor tyrosine
kinases [23,24], we first examined the levels of endogenous
EGFR and ErbB2. In contrast to these previous reports, we
observed a consistent and substantial decline in the steady-state
levels of these receptors in Tsg101 knockout cells compared to
control MEFs (Fig. 1A; also see 1D and 1E). A reduction in the
total and phosphorylated levels of the EGFR was also detected in
Tsg101 knockout cells that stably express exogenous human
EGFR (Fig. 1B). The reduction in the steady state-levels of
EGFR were likely caused by postranslational processes since
Tsg101 deficiency did not affect the level of receptor mRNA as
determined by a semi-quantitative RT-PCR assay (Fig. 1C). This
was also the case for the exogenous human EGFR message, which
was under control of a constitutively-active CMV promoter (data
not shown).
To assess whether the ligand-induced degradation of EGFR
is affected by the lack of Tsg101, we treated control and
Tsg101 knockout cells with EGF for 30 and 60 minutes and
examined the expression of the EGFR (total and phosphorylated)
by western blot analysis. The addition of the ligand led to
the expected decline in the level of EGFR in wildtype control
cells, and a slight reduction in EGFR expression from a lower
baseline was also seen in cells that lack Tsg101 (Fig. 1D).
Concomitant with a decline in the steady-state levels of the
receptor, we observed a decrease in EGF-induced activation of
Erk1/2 in Tsg101-deficient cells compared to their isogenic
controls that express endogenous Tsg101. In conclusion, the
reduction in the steady-state levels of EGFR in Tsg101 knockout
cells was not caused by an enhanced ligand-induced degradation
of the receptor.
Previous studies have reported that an siRNA-mediated
knockdown of Tsg101 led to elevated levels of EGFR due to
enhanced recycling or retention of the receptor within early
endosomes [23,24]. To further examine a cause for our
unexpected findings, we asked whether the reduced expression
of the EGFR in the Tsg101 null cells might be due to differences in
the experimental design, i.e. 72 hrs after siRNA treatment in
previous reports versus 72–96 hrs following expression of Cre and
selection with puromycin in the conditional knockout model. To
address this issue and assess the effects of an acute downregulation
of Tsg101 without the use of a selection agent, we infected Tsg101
conditional knockout cells with an adenovirus expressing Cre
recombinase (AdCre) and examined the steady-state level of the
EGFR over a time course of four days. The expression of Tsg101
started to decline at day 1 following infection with AdCre and was
nearly complete by day 3 (Fig. 1E). Loss of Tsg101 was
accompanied by a gradual reduction in the expression of the
EGFR with a slight delay, becoming apparent after day 2 and with
a steady decline thereafter. The results of this experiment indicate
that the reduction in EGFR is proportional to the gradual decrease
in the level of Tsg101. It might be possible that the absence of a
similar decline in EGFR expression in previous siRNA knockdown
studies might be due to insufficient depletion of Tsg101.
Interestingly, while the overall levels of Erk1/2 remained
unchanged initially and declined at later time points upon
deletion of Tsg101, we observed an increase in the level of
phospho-Erk1/2 that peaked between days 2 and 3 followed
by a decline at day 4 (Fig. 1E). Infection of NIH3T3 cells
(wildtype for Tsg101) with AdCre did not lead to an elevation of
activated MAP kinases (Fig. 1F, lanes 1 and 2), suggesting that the
increase in pErk1/2 levels in AdCre-infected Tsg101
fl/fl MEFs was
not due to adenovirus infection per se but rather due to the lack
of Tsg101.
The increase in the level of active Erk1/2 was observed at a
time when EGFR levels were actually declining, and we therefore
asked whether the elevation in the levels of pErk1/2 in Tsg101
knockout cells was dependent on the presence of growth factors in
the medium. To address this issue, we examined the levels of active
Erk1/2 in mock-infected compared to AdCre-infected cells that
were maintained in the presence or absence of growth factors
(Fig. 1F, lanes 3 through 6). While a higher level of pErk1/2
was seen upon deletion of Tsg101 in cells maintained in growth
factor-containing media, a substantial increase in pErk1/2 levels
was also detected upon Tsg101 deletion in growth factor-deprived
cells. In conclusion, these findings suggest that loss of Tsg101
triggers the activation of ERKs, but this increase is not primarily
the result of a sustained growth factor receptor signaling as
reported earlier.
A knockout of Tsg101 causes a remodeling of actin
filaments as well as an enlargement of lysosomes
without affecting the delivery Cathepsin D into these
distended vesicles
The activation of the mitogen-activated protein (MAP) kinases
in a growth-factor independent manner as well as the initiation of
a cell cycle arrest are both indicative for a stress adaptation of cells
following the deletion of Tsg101. The redistribution of actin
filaments is another characteristic of stressed cells, and we
therefore anticipated obvious changes in the architecture of the
cytoskeleton in Tsg101 knockout cells. The phalloidin-based
fluorescent staining of F-actin in Tsg101-deficient cells compared
to wildtype controls (Fig. 2A) clearly shows that deficiency in
Tsg101 led to a pronounced widespread reorganization of actin
filaments with few branches. It has been proposed recently that F-
actin remodeling is a necessary event that precedes the fusion of
the autophagosome with the lysosome [29], which is a key event
for the integrated stress response. Indeed, Tsg101-deficient cells
exhibited greatly enlarged Lamp1-positive lysosomes that often
had a ring-shaped appearance (Fig. 2C). Although it had been
reported that a knockdown of Tsg101 caused multiple trafficking
defects [23,24], we observed that the routing of biosynthetic cargo
from the Golgi and delivery of nascent lytic hydrolases to the
lysosome were not impaired in cells that are conditionally deficient
in Tsg101 (Fig. 2B, 2C). Cathepsin D, which appeared to be more
abundant in Tsg101-deficient cells, was clearly present within the
lumen of the enlarged lysosomes. In addition, lack of Tsg101 did
not appear to affect the size or morphology of the cis-medial golgi
as determined by staining with antibodies against giantin and
GM130 (data not shown). Collectively, these observations suggest
that a knockout of Tsg101 does not generally block the delivery of
cargo to the lysosome, but it initiates a number of events including
the remodeling of actin filaments and the enlargement of
lysosomes that might be a consequence of an induction of
autophagy.
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localization with lysosomes is indicative of the induction
of macroautophagy in response to Tsg101 deficiency
To assess whether Tsg101 deficiency leads to the initiation of
macroautophagy, we examined the mRNA level of the Microtubule-
associated protein 1/light chain 3 (Map1lc3) gene as well as the
expression and intracellular localization of its encoded protein,
LC3. As a mammalian homolog of the yeast Atg8, LC3 is a
constituent of the autophagosome. The quantitative RT-PCR
showed that the transcriptional activation of the Map1lc3 gene was
approximately 8 to 10 times higher in Tsg101 knockout cells
compared to their wildtype controls (Fig. 3A). Unlike in wildtype
cells that were grown in the presence of serum, the withdrawal of
growth factors led to the expected increase in the level of the LC3
protein (Fig. 3B). Similar to serum starvation, the conditional
deletion of the Tsg101 gene led to a significant elevation in LC3
expression despite the presence of growth factors.
Next, we used immunofluorescence staining and confocal
microscopy to assess the intracellular distribution of endogenous
LC3. A co-staining of this autophagy-related protein with a
lysosomal marker clearly shows that LC3 is abundant and highly
enriched within Lamp1-positive structures in cells that lack Tsg101
(Fig. 3C, 3D). To confirm these findings, we transfected Tsg101
Figure 2. Remodeling of actin filaments and enlargement of lysosomes in response to the conditional deletion of the Tsg101 gene.
A. Confocal microscopic images of a phalloidin-based fluorescent staining of F-actin in Tsg101 conditional knockout cells (Tsg101
2/2) and their
controls (Tsg101
fl/fl). B., C. Co-staining of Tsg101-deficient cells and their wildtype controls with antibodies against Lamp1 and Cathepsin D; panel B
illustrates the quantitative analysis of the colocalization of both signals (P value, t test). Note that Cathepsin D, which was more abundant in Tsg101-
deficient cells, was clearly present within the lumen of the enlarged lysosomes (panel C, arrows). Bar in panel C represents 10 mm.
doi:10.1371/journal.pone.0034308.g002
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EGFP-tagged LC3 protein. As anticipated, a moderate increase in
the co-localization between LC3-EGFP and lysosomes was
observed in wildtype cells that were maintained without growth
factors (Fig. 4). The extent of the association between these
markers was more pronounced in Tsg101 knockout cells due to
the presence of greatly enlarged Lamp1-positive vesicles, which
frequently exhibited an accumulation of LC3-EGFP within their
lumen (Fig. 4, bottom panel, arrows). Collectively, the results of
this study show that deficiency in Tsg101 causes an increase in the
expression of LC3 and an enrichment of this protein within
distended lysosomes, which all are indicative of the induction of
macroautophagy.
Tsg101-deficient cells initiate autophagy to extend their
survival before they undergo apoptosis
The inclusion of LC3 as well as the Cathepsin D protease into
the greatly enlarged lysosomes suggested that Tsg101 knockout
cells contain functional autophagolysosomes that are able to
sequester organelles and degrade their content. The formation of
autophagosomes that subsequently fuse with endosomes and
lysosomes to mature into autophagolysosomes is initiated by the
Figure 3. Tsg101 deficiency leads to induction of macroautophagy. A. Quantitative real-time RT-PCR to assess the transcriptional activation
of the Microtubule-associated protein 1/light chain 3 (Map1lc3) gene in Tsg101 conditional knockout cells and their wildtype controls. B. Western blot
analysis to verify the increase in expression of LC3 in response to Tsg101 deficiency. Wildtype cells maintained in the absence of growth factors (GF)
were used as a positive control. C., D. Analysis of confocal images of Tsg101 conditional knockout cells and their wildtype controls that were
maintained in the presence or absence of growth factors (GF) prior to fixation and co-staining with antibodies against endogenous LC3 and Lamp1.
Panel C illustrates the quantitative analysis of the colocalization of LC3 and Lamp1 (P value, t test). The bar in panel D represents 10 mm and arrows
indicate areas of intensive co-localization of LC3 and Lamp1.
doi:10.1371/journal.pone.0034308.g003
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with a PI3 kinase inhibitor, 3-methyladenine (3MA), has been
demonstrated to attenuate autophagy which subsequently leads to
accelerated cell death [30]. To assess the importance of autophagy
as a survival mechanism for stressed Tsg101-deficient cells, we
treated these cells and their wildtype controls with 3MA to block
the maturation of functional autophagolysosomes. The immuno-
fluorescent staining of LC3 and Lamp1 in treated Tsg101-
deficient cells compared to their untreated knockout controls
showed that the PI3 kinase inhibitor led to a decrease in the
expression and dissociation of LC3 from the lysosome (Fig. 5A,
5B). Despite the lack of co-localization of the two markers, some of
the Lamp1-positive structures remained enlarged. Next, we
examined whether blocking the formation of functional autopha-
golysosomes was sufficient to accelerate the death of Tsg101
knockout cells that are destined to succumb from the loss of this
gene. Although treatment of wildtype fibroblasts with 1.5 mM
3MA showed some degree of toxicity, Tsg101-deficient cells were
much more sensitive to the PI3 kinase inhibitor (Fig. 5B). The
observation that the treatment of Tsg101-deficient cells with 3MA
causes accelerated growth arrest and cell death may suggest that
stressed Tsg101 knockout cells utilize autophagy as a mechanism
to prolong their survival prior to their ultimate demise.
In a complementary study, we treated cells with bafilomycin A1
to further assess the correct functionality autophagolysosomes.
Bafilomycin A1 is a vacuolar type H
+-ATPase inhibitor that
suppresses macroautophagy by preventing acidification of lyso-
somes, which, in turn, causes an increase in LC3 and reduces the
cleavage and activation of Cathepsin D. As shown in Fig. 6, loss of
Tsg101 resulted in an increase in the steady state levels of LC3
(both LC3-II and its precursor LC3-I) as well as Cathepsin D
(CtsD), in particular the activated form (CtsD, heavy chain). As
expected, treatment of these knockout cells and wildtype controls
with bafilomycin A1 increases the expression of LC3 and mainly
the unprocessed precursors of Cathepsin D (CtsD, prepro and
pro). The reduction in the activated form of Cathepsin D in
Tsg101-deficient cells that were treated with bafilomycin A1
compared to knockout cells without the inhibitor indicates that the
autophagolysosomes in the Tsg101-deficient cells are functional.
Expression of exogenous Tsg101 in knockout cells
reverses the autophagic process
We have shown previously that re-expression of an HA-tagged
Tsg101 protein in conditional knockout cells that lack both
endogenous Tsg101 alleles lifts the cell cycle block and promotes
their survival [12]. We repeated this rescue experiment as
illustrated in Fig. 7A to assess whether the induction of autophagy
can be averted through expression of exogenous Tsg101 in the
complete knockout background. The results of this study
demonstrated that reinstating the functionality of Tsg101 lowers
the level of the autophagy-associated protein LC3 and reduces the
expression of active Cathepsin D (Fig. 7B). Finally, we used
immunofluorescence staining of LC3 and Lamp1 to verify that
restoring the expression of exogenous Tsg101 causes a dissociation
of any remaining LC3 from the lysosome. The confocal analysis
clearly showed that the intense co-localization of both markers that
Figure 4. Accumulation of exogenous LC3-EGFP within the distended lumen of Tsg101 knockout cells. Confocal images of Tsg101
conditional knockout cells and their wildtype controls that were transfected with an LC3-GFP expression vector and maintained in the presence or
absence of growth factors (GF). Cells were fixed and stained with an antibody against Lamp1; bar represents 10 mm.
doi:10.1371/journal.pone.0034308.g004
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the expression of Tsg101 was reinstated (Fig. 7C, 7D). This
suggests that the induction of autophagy is a direct and reversible
cellular stress response that is caused by the loss of Tsg101.
Discussion
Although cause and phenotypic consequences of a complete
ablation of Tsg101 are difficult to discriminate due to the
complexity of the intracellular changes, our study provides
evidence that deficiency in Tsg101 leads to a gradual decrease
in the steady-state levels of the EGFR and ErbB2 within a period
of 4 days when a significant number of Tsg101 knockout cells
remained viable. At no given time point did we observe an
increase in the expression of the EGFR that would indicate that
loss of Tsg101 enhances the recycling of the receptor back to the
cell membrane or promotes a retention of the EGFR within the
endosomal compartment as previously suggested [10,23,24]. More
Figure 5. Tsg101-deficient cells initiate autophagy to prolong their survival prior to cell death. A. Confocal images of wildtype cells and
Tsg101 conditional knockout cells that were grown in the presence or absence of 3-Methyladenine (3MA) to inhibit the fusion and maturation of LC3
containing autophagosomes with lysosomes. Tsg101-deficient cells were maintained in the presence of the inhibitor following one day after deletion
of Tsg101 using an adenovirus-based delivery of Cre recombinase; bar represents 10 mm. B. Quantitative analysis of the colocalization of LC3 and
Lamp1 following 2 and 3 days of treatment with 3MA (P value, t test). C. Counts of Tsg101-deficient cells and their controls following treatment with
1.5 mM 3MA. The inhibitor was administered 24 hrs after infection with AdCre and deletion of Tsg101.
doi:10.1371/journal.pone.0034308.g005
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and is thought to primarily recycle, our findings that Tsg101
deficiency results in lower expression levels of this receptor raises
the possibility that Tsg101 may regulate sorting processes distinct
from the known effects of Tsg101 on promoting ubiquitinated
cargo sorting into multivesicular bodies.
Similar to a knockout of Tsg101, the genomic deletion of the
genes encoding the EGFR and ErbB2 causes embryonic lethality
in mice [31,32]. It can therefore be assumed that a substantial
decline in the steady state levels of both receptor tyrosine kinases in
response to Tsg101 deficiency acts as a cellular stressor that is
comparable to growth factor deprivation. In our previous studies
and in this report, we provide several lines of evidence that Tsg101
deficiency leads to an extensive cellular stress response that is
characterized by 1) a p53-mediated cell cycle arrest, 2) the
induction of stress kinases in the absence of growth factors, 3) an
excessive remodeling of the actin filaments, as well as, 4) an
enlargement of lysosomes and induction of autophagy. These
complex changes in various molecular pathways need to be
recognized as they can have a significant impact on defining
particular functions for Tsg101 in processes such as protein
sorting, trafficking, and signal transduction. For example, the
intracellular targeting of activated Src is dependent on the actin
cytoskeleton [33]. Since deficiency in Tsg101 causes a widespread
redistribution of actin filaments, this might, in part, explain why
Tsg101 is important for targeting Src to focal adhesions [34].
We observed that Tsg101 knockout cells contain greatly
distended Lamp1-positive lysosomes. Although we did not
examine the specific kinetics of the routing of biosynthetic cargo
and nascent lytic hydrolases, it is evident from the results of this
study that Tsg101 is not essential for the delivery of cargo such as
Cathepsin D to the lysosome as reported previously [10]. In
addition, the lysosomal compartment in Tsg101 knockout cells
appears to be functional based on the correct cleavage and
activation of Cathepsin D. The normal processing of this protease
in the Tsg101 knockout cells could be inhibited through
administration of bafilomyin A1, which is known to increase the
pH in lysosomes and endosomes [35]. It has been proposed
recently that the various ESCRT complexes including Tsg101 are
required for the autophagic degradation of certain protein
aggregates that are associated with neurodegenerative diseases
[25]. While depletion of Tsg101 with siRNAs did not lead to an
increase in Map1lc3 mRNA expression, the level of the LC3-II
protein was elevated in HeLa cells where Tsg101 was knocked
down. Expression of an LC3-GFP fusion protein also led to the
formation of large aggregates with p62, and it was suggested that
this was the result of an inhibition of the degradation of both
proteins due to impaired autophagolysosome formation. It cannot
be excluded that these observed abnormalities might specific for
HeLa cells or the type of functional ablation of the Tsg101 protein
in these and other cells. The conditional knockout of the Tsg101
gene on the genomic level in normal fibroblast did not block the
delivery and Cathepsin D to the lysosome and its processing at this
cell organelle, and, more importantly, the extensive co-localization
between the lysosomal protein Lamp1 with endogenous LC3 (see
Figs. 3C, 5A, and 7) suggests that lack of Tsg101 did not prevent
the fusion between autophagosomes and lysosomes. This assump-
tion is supported by the fact that Tsg101 conditional knockout cells
increase the expression of LC3 on the transcriptional level in
response to cellular stress, and they use autophagy to extend their
survival prior to cell death.
As our previous studies and this report show, the G1/S cell cycle
arrest, the induction of autophagy, and survival of cells that lack
both copies of the endogenous Tsg101 gene can be completely and
permanently rescued through expression of exogenous wildtype
Tsg101 from a retrovial vector. At this point, it is still unclear,
which of the proposed multifaceted functions of Tsg101 are
actually essential for the survival and normal homeostasis of a
mammalian cell. Also, the biological relevance of the interaction
between Tsg101 and other proteins including members of the
ESCRT-1 complex and suggested ubiquitinated cargo proteins has
not been examined in vivo. The more in-depth phenotypic
characterization of Tsg101 conditional knockout cells on the
intracellular level is a first step in this direction. Since the levels of
Tsg101 are precisely controlled within a narrow range in normal
cells [12,14], the rescue experiment described in this study leads to
the generation of stable cell lines that only express exogenous
Tsg101 at physiologically relevant levels. This methodology is now
being employed to assess the importance of particular domains of
the Tsg101 protein through expression of mutant forms of this
protein in cells that lack both endogenous Tsg101 alleles.
Materials and Methods
Cell cultures and Cre-mediated deletion of Tsg101
The generation and propagation of immortalized mouse
embryonic fibroblast (MEFs) from 13.5 or 14.5-day-old Tsg101
fl/fl
embryos was described previously [12,14]. Forty-eight hrs after
infection of these cells with a pBabe-Cre-puro retroviral vector or
pBabe-puro control vector, cells were selected in complete medium
containing 7 mg/ml puromycin (Sigma) as described [12,13]. For
the adenoviral-based delivery of Cre recombinase, cells were
infected with the AdCre vector at an MOI of 5 in regular DMEM
for 90 min with frequent agitation. Fresh media was added and the
cells were incubated overnight. The AdCre containing media was
replaced the next morning.
Western blot analysis
A detailed description of the preparation of whole-cell extracts
of clarified cell lysates and experimental procedures for western
blot analyses was described earlier [12,14]. The following
antibodies were used in this study: a-Tsg101 (C-2) (1:1000
Figure 6. Tsg101 knockout cells exhibit increased expression
of LC3 and activated Cathepsin D. Western blot analysis of LC3 as
well as active Cathepsin D (CtsD) and its unprocessed precursors in
Tsg101 knockout cells and their controls. Both types of cells were
treated with bafilomycin A1 to assess the functionality autophagolyso-
somes. Note that treatment of Tsg101-deficient cells with this inhibitor,
which prevents the acidification of lysosomes, reduces the level of
processed Cathepsin D.
doi:10.1371/journal.pone.0034308.g006
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(sc-12351) from Santa Cruz Biotechnology; a-EGFR (1:200
dilution) from AbCam; a-ErbB2 (Her2/Neu) (OP-15) (1:1000
dilution) from Calbiochem; a-phospho-ERK (1:5000 dilution)
from Cell Signaling Technology, a-pan-ERK (1:2000 dilution)
from BD Bioscience; and a-Map1LC3 (4E12) (1:2000 dilution)
from MBL International. Horseradish peroxidase-conjugated
secondary antibodies were purchased from Santa Cruz Biotech-
nology and used at a dilution of 1:1000. The Cathepsin D
antibody was a generous gift from Dr. Kurt von Figura, President
of the Georg-August-Universita ¨t Go ¨ttingen, Germany.
RNA extraction, semi-quantitative and quantitative RT-
PCR
Total RNA was extracted from cells using standard guanidi-
nium thiocyanate-phenol-chloroform extraction. A Superscript II
kit from Invitrogen with Oligo(dT) primers was utilized to perform
the fist strand synthesis. PCR amplification of the mouse Epidermal
Growth Factor Receptor (EGFR) transcript was performed using the
following primer pair: 59-AAT GGG AGC TGC CGT GTC AAA
GA-39 and 59-TAA ACC CAC TAC TGA GAC AGG TA-39.A
semi-quantitative analysis of the PCR amplicons on agarose gels
Figure 7. Permanent rescue of Tsg101 knockout cells from the stress-induced induction of autophagy through expression of
exogenous, HA-tagged Tsg101 from a retroviral vector. A. Experimental design. B. Western blot analysis to verify the reduction in the levels
of LC3 and Cathepsin D (CtsD) upon re-expression of Tsg101. C., D. Analysis of confocal images of Tsg101 conditional knockout cells with and
without exogenous HA-tagged Tsg101 and their wildtype controls that were co-stained with antibodies against endogenous LC3 and Lamp1. Panel C
illustrates the quantitative analysis of the colocalization of LC3 and Lamp1 (P value, t test). Bar in panel D represents 10 mm.
doi:10.1371/journal.pone.0034308.g007
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Hypoxanthine Phosphoribosyltranferase (Hprt) severed as loading control.
Quantitative detection of Map1lc3 was performed using the
TaqMan Mastermix (Applied Biosystems, Foster City, CA) with
addition of Map1lc3- and Gapdh-specific primers and probe sets
(Mm007828698_sH and 4352339E). The quantitative PCRs
(qPCRs) were carried out in triplicate in a CFX96 real-time
PCR detection system (Bio-Rad, Hercules, CA). The expression
values obtained were normalized against Gapdh standard curve
generated from the same samples.
Transfection of plasmid expression vectors
The mammalian expression vector for the EGFP-LC3 fusion
protein [36] was obtained from Addgene (plasmid 11546). Cells
were transiently transfected 48–72 hrs prior to confocal analysis
using either FuGENE (Roche Diagnostics) or Lipofectamine
(Invitrogen) reagents. The pcDNA3-hEGFR plasmid was a kind
gift from William Muller (McGill University). For stable expression
of the hEGFR, transfected cells were selected with 200 mg/ml
hygromycin B.
Immunofluorescent staining and confocal microscopy
Tsg101-deficient and control cells were grown on poly-L-lysine
coated glass coverslips. Cells were fixed with a solution of 4% (v/v)
paraformaldehyde in PBS for 10 min. Next, cells were blocked in
staining solution (0.2% (w/v) saponin, 10% (w/v) bovine serum
albumin/PBS) for 30 min before incubation with appropriate
primary antibody for 45–60 min at room temperature. Primary
antibodies used in these studies include a-Cathepsin D (1:500), and
a-Lamp1 (1:800) antibody that was purchased from Santa Cruz
Biotechnology. The Cathepsin D antibody was a generous gift
from Dr. Kurt von Figura, President of the Georg-August-
Universita ¨t Go ¨ttingen, Germany. The a-Map1lc3 (1:500 dilution)
antiserum was obtained from MBL International, and the Alexa
Fluor 594-labeled phalloidin was purchased from Invitrogen.
Coverslips were washed four times in 16 PBS before being
incubated with an appropriate secondary antibody for 30 min.
Corresponding secondary antibodies conjugated to Alexa Fluor
dyes 405, 430, 488, 568, or 594 were purchased from Invitogen.
Labeled anti-mouse and anti-rat antibodies were used at a 1:800
dilution, while anti-rabbit antibodies were used at a 1:1500
dilution. Coverslips were mounted on slides using about 25–50 ml
of Vectashield mounting medium with 49,6-diamidino-2-pheny-
lindole (DAPI) (Vector) and sealed with clear nail polish. Cells
were visualized with a LSM 5 Pascal confocal microscope (Carl
Zeiss, Thornwood, NY) using a 6361.4 numerical aperture
objective and filters appropriate for the various fluorochromes
used.
Inhibition of autophagy using 3-Methyladenine and
bafilomycin A1
Following adenoviral-mediated expression of Cre recombinase,
Tsg101-deficient cells and their controls were maintained for 1, 2,
and 3 days in the presence of 1.5 mM 3-Methyladenine (3MA).
For confocal microscopic analysis, cells were fixed on the third day
in 4% paraformaldehyde and stained with anti-Lamp1 and anti-
LC3 antibodies. To assess the survival rate during a 3-day time
course in the presence and absence of 3MA, Tsg101-deficient cells
and their controls were seeded into 6-well plates at a density of
33,000 cells per well. Cells were harvested, stained with Trypan
blue (Invitrogen), and viable cells were counted on the three
consecutive days following administration of 3MA. To modulate
the autophagic process using bafilomycin A1, cells were infected
with AdCre and maintained in fresh growth media overnight. The
growth media was replaced the next day, and 10 nM of
bafilomycin A1 was added. Cells were harvested for western blot
analysis after an overnight incubation with the drug.
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